Business Description
Founded in Switzerland in 1993, BB Biotech AG is an investment fund that focuses on publicly traded companies developing medicines and diagnostic tools through biotechnology. The fund is managed by Bellevue Asset Management AG, which uses in-depth company research to select holdings from markets around the world.
